However, since hERG1 contributes to the repolarization of the heart action potential, so-called “torsadogenic” hERG blockers may delay cardiac repolarization and, therefore, substantially increases the risk of Torsade de Pointes and sudden cardiac death. This evidence concerns the gene KCNH2 and event death.